Jill MacAlpine

Jill K. MacAlpine’s practice includes patent litigation, counseling, and prosecution, primarily in the chemical and pharmaceutical areas. With 15 years of experience in intellectual property law, she spends a significant portion of her time involved in pre-litigation analyses, due diligence investigations, opinion preparation, and strategic client counseling, including patent portfolio management, Orange Book listings of patents covering FDA-approved drugs, and patent term extensions.

As a registered patent attorney, Jill has extensive experience in handling a wide variety of patent matters before the U.S. Patent and Trademark Office (USPTO), including post-grant proceedings specifically inter partes reviews (IPRs), appeals, and oral hearings at the Patent Trial and Appeal Board (PTAB); drafting and prosecution of patent applications; reissue and reexamination proceedings; and interferences.

In addition to counseling and prosecution, Jill’s practice includes patent litigation, in particular Abbreviated New Drug Application (ANDA) cases arising under the Hatch-Waxman Act.

She has experience in all aspects of patent litigation, at both U.S. district court and appellate levels, including managing day-to-day activities during every phase of litigation, conducting offensive and defensive discovery, drafting dispositive motions, and taking and defending depositions.

Furthermore, Jill has been extensively involved in matters procuring, assessing and/or defending patent rights related to pharmaceuticals drugs, including Lovenox®, Taxotere®, Allegra®, Rimonabant,® Nuvigil®, and Gabitril®, and other products such as Cerament.

Jill has handled matters involving a wide range of technologies, many having complex issues concerning solid state forms (polymorphs), including pharmaceuticals, small molecule chemistry, cosmetics, food science, bone substitutes, polymers, and drug delivery systems. Jill also has significant experience in organic chemistry.

She earned her Ph.D. in organic chemistry at the University of British Columbia, where she studied porphyrins and porphyrin derivatives for use as pharmaceutical products in photodynamic therapy.

Jill has written and lectured on diverse patent law issues and is a permanent faculty member of the Patent Resource Group’s “Chemical Patent Practice,” a comprehensive U.S. chemical patent law course taught multiple times a year.

Education :

• George Washington University Law School J.D., with highest honors, 2003
• University of British Columbia Ph.D., Organic Chemistry, 1999
• Queen’s University B.S., Chemistry, with honors, 1993

Admissions :

• District of Columbia
• Virginia
• U.S. Patent and Trademark Office

Professional Activities :

• American Intellectual Property Law Association
• American Chemical Society
• Virginia Bar Association
• District of Columbia Bar Association
• Boston Patent Law Association
• Order of the Coif